A haplotype relative risk study of the dopamine D4 receptor (DRD4) exon III repeat polymorphism and attention deficit hyperactivity disorder (ADHD)

Am J Med Genet. 2000 Jun 12;96(3):258-61. doi: 10.1002/1096-8628(20000612)96:3<258::aid-ajmg4>3.0.co;2-8.

Abstract

Attention deficit hyperactivity disorder (ADHD) is a developmental syndrome expressed along three domains: inattention, hyperactive-impulsive, and combined type. Several investigations have recently examined the role of the dopamine DRD4 exon III repeat polymorphism in ADHD. The long 7 repeat allele of this receptor was shown in three family-based studies, but not in one case control design, to be a risk factor for this disorder. We now report an additional family-based study of DRD4 exon III repeat region and ADHD. However, in the current study we fail to observe preferential transmission of the DRD4 exon III long 7 repeat allele, chi(2) = 0. 142, P < 0.1, df = 1. Nor was any preferential transmission observed when genotypes were compared, chi(2) = 0.180, P > 0.1, df = 1. Possible reasons are discussed, especially lack of sufficient power in analying more refined phenotypes, why the current results in contrast to previous findings fail to support a role for the long form of the DRD4 receptor as a putative risk factor for ADHD.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Alleles
  • Attention Deficit Disorder with Hyperactivity / genetics*
  • Case-Control Studies
  • Chi-Square Distribution
  • Child
  • Exons
  • Haplotypes
  • Humans
  • Polymorphism, Genetic
  • Receptors, Dopamine D2 / genetics*
  • Receptors, Dopamine D4
  • Risk
  • Risk Factors
  • Tandem Repeat Sequences

Substances

  • DRD4 protein, human
  • Receptors, Dopamine D2
  • Receptors, Dopamine D4